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1. Introduction
Medicine is becoming increasingly dependent on new technologies and they have big impact on
its practice. An important aspect of these technologies is that most of them also generate large
amounts of digital data that need to be stored. Unfortunately, data, even big data, have no value
until they are analyzed with the goal of discovering new and actionable knowledge, which would
potentially benefit patients and communities.
Medicine is becoming Predictive, Preventive, Personalized and Participatory, a rubric known
as P4 medicine [41]. Using systems medicine, defined as application of systems biology to human
disease [48], we are able to predict the probability of a disease. Predictability, in turn, makes
prevention possible, for example the implementation of measures to either prevent the disease or
reduce its impact on patients. These approaches allow for increased personalization, also known
as precision medicine. This realization came from simple observation that drugs, treatments and
procedures do not work in the same way in different patients. However, by obtaining additional
data about a patient, like genetic profile, the treatments can be fined-tuned. New technologies also
support growth of participatory medicine, also known as patient-centric medicine. With the spread
of the Internet and social networks, patients and families have moved from passive recipients of
healthcare to well-informed partners, who co-decide the course of their treatments.
Healthcare data security. Huge volume of healthcare data collected on patients has poten-
tially enormous value but keeping that data secure poses a formidable challenge. There is a growing
importance of data security [47], as mandated by regulations such as Health Insurance Portability
and Accountability Act (1996) and the Genetic Information Nondiscrimination Act (2008). The
two acts set standards for the electronic exchange, privacy and security of health information, or
the misuse of genetic information, e.g., for health insurance or employment decisions. However,
no healthcare data security system is foolproof in spite of using the new technologies that better
secure their storage and transfers [20]. Following the rules that exist in some countries, but not
globally [111], is not sufficient as there is always a human factor involved in securing the data
[104]. The factors threatening data security range from innocent human mistake that can make
data vulnerable to malicious players, to the human greed that opens data to the highest bidder.
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The collection of healthcare data occurs also at social media giant tech corporations [39]. Data
collected on all of us, such as by Facebook, can be and are used for dubious purposes like social
engineering and marketing, along with potentially good purposes [32]. Unfortunately we have
witnessed huge data breaches (Facebook, Yahoo) that make data available to bad players. Some
new technologies can alleviate this problem, for instance, using blockchain technology leaves a
trace of every transaction performed, such as sending data from one hospital to another, but this
works only for official data transfers, as blockchain cannot prevent data from being hacked or
stolen. Because of the latter, we shall talk about P5 medicine, by adding the Privacy-preserving
attribute to the predictive, preventive, personalized, and participatory. It is a new task, to develop
technologies to better protect health data in the future.
New technologies and medical data mining. We describe below how new technologies,
several of which came into being since publication of our original paper on the uniqueness of
medical data mining [25], that collect large-scale heterogeneous medical data on individuals and
populations, are changing the field of medicine. Examples of data generated by those technologies
are image and omic (genomic, proteomic, etc.) data. Below, we highlight the biggest changes that
have occurred since the Cios and Moore paper [25].
Human medical data are at the same time the most rewarding and difficult of all biological
data to analyze [101]. Humans are the most studied species on earth and data and observations
collected on them are unique and cannot easily be gained from animal studies. Examples are
visual, cognitive and perceptive data, such as those relating to discomfort, pain and hallucinations.
Animal studies, being shorter, cannot track long-term disease processes, such as atherosclerosis.
Since the majority of humans have had at least some of their medical information collected in digital
form, this translates into big data. Unfortunately, analyzing human data is not straightforward
because of the ethical, legal, social and other constraints that limit their use. Hospitals are the ones
who store majority of medical data, however, many of them have little interest in sharing them,
which adversely impacts global healthcare by restricting large-scale data analysis and new findings.
While the current trend is towards open-access data and collaborative environments, issues related
to medical data privacy and market competition are not easily alleviated.
On the technology side we have seen creation of disruptive technologies such as blockchain,
cloud computing, wearable devices, and augmented reality. A disruptive technology does not have
to be an entirely new one: often it has been long-existing but was greatly improved in terms of,
for instance, speed or accuracy. Examples of the latter technologies are artificial intelligence (AI)
and machine learning [9], natural language processing (NLP) [110], image understanding [33] and
robotics [31]. They all call for new ways of looking at medical data. As an example, a system
called nEmesis, based on NLP, was developed to identify restaurants reported by customers on a
Twitter as a source of the food-borne illnesses [94]. The system collects that and allows health
officials to quickly localize impact of a spreading disease. Another example is a system to identify
patients who truly need a massive blood transfusion, avoiding frequent overtransfusion, a bad use
of a limited resource such as blood bank [107].
There is a growing need for medical standardization and benchmarking to allow for fair com-
parisons of procedures across physicians and hospitals [82]. We illustrate this need and how it
was solved in the field of data mining. Before standardization, each data mining researcher had
to create their own software to analyze data. This was an enormous waste of time, prone to sig-
nificant variations among different implementations of the same algorithms. A fair and unbiased
comparison of the methods was practically impossible, which reduced their impact and spread of
practical applications. To address this issue, researchers developed well-tested software packages
for almost all types of machine learning algorithms: examples are MATLAB (commercial) [59] or
WEKA (free) [16]. Similar process took place in statistics for validating models generated by ma-
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chine learning algorithms [14, 34]. These statistical methods also became part of software packages,
including in the two just mentioned. Statisticians went even further and addressed problems with
already published papers [29]. A web-based algorithm called statcheck checks validity of statistical
testing used in papers; it reads both pdf and HTML formats of papers and recalculates p-values
and other measurements [85]. Another statistical example is G*Power software for computing sta-
tistical power for t-tests, F -tests, z-tests used for design of experiments to determine effect sizes
[38]. Developments such as those contribute toward improving transparency and reproducibility of
research results, which remains a problem even in top journals, although some publishers addressed
this problem by requiring that both data and software must be published along with the reported
results.
There are no similar benchmarks for medical evaluation, management and procedures because
medical practice is still a mixture of art and science [109]. For instance, is it possible to objectively
compare the outcome of two brain surgeries for the same type of cancer diagnosed at the same stage
and located at about the same brain region? Can certain clinical scenarios be similar enough to be
analyzed similarly for the good of patients? More importantly, can health care outcomes be fully
standardized [112]? On the positive side, the metric of patient satisfaction is now tracked nationally
since lawmakers have tied this to the Center for Medicare and Medicaid (CMS) reimbursements.
Epidemiologists have been lumping together similar cases to measure outcomes in large population-
based studies and some clinical practice guidelines have resulted from them [13, 65]. For example,
the Framingham heart study [76] regarding risk factors of cardiovascular disease has given rise to
practical management tools for the clinician, such as calculators for the risk of atrial fibrillation
or stroke under various conditions. These help identify and standardize conditions under which
physicians offer patients certain treatments like blood thinners. However, more performance-based
metrics are still need to be developed.
New technologies demand new way of educating medical doctors. Because modern
medicine heavily depends on technology there is a need for physicians to understand the technologies
they use [98]. Some physicians deal with this problem by updating their technological know-how
on their own, but this is not easy and they can learn only about a few such developments and at
only a rather superficial level. As a side note, there are about 34,000 journals and they publish
about 3 million papers each year.
To address the problem of changing technologies, and medicine becoming more technical, new
ways of teaching it are being implemented to train physicians. Almost all medical curricula incor-
porate training in the use of electronic health records and searching for necessary data in databases
such as Cerner or Epic. A drastically different paradigm to medical education, however, was de-
veloped and implemented at Carle Illinois College of Medicine, jointly funded by the University
of Illinois at Urbana Champaign and the Carle Health System. The College requires that all ap-
plicants, in addition to the typical medical curriculum also have knowledge of computer science,
mathematics and statistics. Importantly, it is the first school that teaches each medical subject
from three perspectives: biological, clinical and engineering. It is done by having three instructors
to teach each topic; for instance, while learning about the cardiovascular system they also learn,
from different instructors, about fluid dynamics and genetics. During clinical rotations they are
required to identify technological solutions that are or can be applicable to the disease/problem
investigated. One of the Colleges goals is that by utilizing more technological solutions, including
software such as AI and machine learning, the cost of medicine will decrease. The latter is especially
important in the U.S., which has by far the highest costs of medical practice of any country [103].
The rest of this paper is organized as follows. Section 2 discusses the issue of heterogeneity
of medical data, Section 3 focuses on data mining issues, Section 4 touches upon legal, ethical
and social issues, while Section 5 emphasizes special status of medicine. We end with concluding
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remarks.
2. Heterogeneity of medical data
Cios and Moore [25] in the section under the same heading focused on volume and complexity
of medical data, importance of physicians interpretation, sensitivity and specificity analysis and
poor mathematical characterization. All these topics but the first are as valid now as they were
then. The volume and complexity of the medical data, however, has increased exponentially as
massive amounts of data are being collected daily on patients, populations, as well as on healthy
individuals.
2.1. Sources of medical data
The reality is that now it is much easier to collect and store big data than to analyze them.
As a result large amounts of the already collected are never analyzed [10]. One of the reasons for
the latter is that data capturing technologies change rapidly and it makes little sense to analyze
data collected with the use of old technology. For example, every few years the resolution of images
improves by orders of magnitude so analyzing data collected with a much lower resolution makes
no sense. At the extreme, it is now possible to use bioluminescence imaging to visualize, measure
tumor growth, and even observe cell-to-cell interactions [52].
Out of the ten biggest companies in the world, seven are information technology companies, of
which five are American. Although only one of them is a healthcare company (Johnson&Johnson),
almost all of them have large presence in the area of health care. The result is rapid growth of
sources and amounts of health data generated. Below we list some sources responsible for medical
data exponential growth:
• EHR (Electronic Health Records). In 2002 less than 20%of American hospitals have had fully
implemented EHR systems but now more than 90% do [30]. US hospitals now generate about 50
Petabytes (50x1015 bytes) of data per year; yet only about 3% of it is fully analyzed [36].
• Patient rights. Because of increasing patient rights, almost all hospitals now allow patients to see
and download their records [51]. Note, that this increases risk of security breaches.
• Genomic and proteomic data. The cost of analyzing a human genome went down from millions
of dollars since its decoding in 2001 to hundreds of dollars now. This translates into exponential
increase of genomic, protein, DNA, RNA, nucleotide sequences, protein structure, microarray etc.
data collected.
• PubMed publications. Medical research results, measured by publications, double every few years.
For example, the number of genotyping articles, which identify variations in specific pre-defined
single polymorphisms within a gene, grew ten-fold since 2002 to over 1000 now. The number of
sequencing articles, looking for variations throughout the entire gene, grew from few to about ten
thousand. In addition to the published articles, many publishers now also require publishing data
and software used for analyzing them; the purpose being that the results can be repeated and
verified by others.
• FDA-approved tests for at home use. The number of such tests, those that do not do any harm
to a human, and that are fairly accurate, doubled since 2002.
• Clinical trials. Their number has increased by an order of magnitude since 2002.
• Smartphones and wearable devices. With the proliferation of smartphones and the non-invasive
devices came an increase in the number of downloads of health-related apps [55]. The majority of
the latter are for physical conditioning purposes but also for diseases, treatments, stress reduction,
diet, nutrition, etc.
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• Medical imaging data. Medical imaging has made significant advances over the last two decades
[45]. New devices allow for more precise monitoring of not only static but also of dynamic changes.
Therefore, visual data now also include time-related information: such imaging is known as 4D
imaging (red/green/blue/time).
• Social media text data. The role of social media has exponentially grown in the last two decades.
As people are sharing details about their well-being and seek others in similar situations, social
media is another big source of medical data [73]. For instance, Twitter microblogs with geo-
localization are used for tracking the spread of viral diseases. Social media has changed the way we
look at individual and population-level health issues. Patients seek medical information online on
websites such as WebMD and the websites of large medical centers or disease-specific foundations.
They communicate with each other about symptoms and share personal experiences [61]. Physicians
also use social media, such as professional networking sites like Doximity, Sermo and Doc2Doc.
These allow using opinions of a community or understand the standard of common medical opinion
or practice [72]. It is difficult to efficiently store and process these data but they contain invaluable
insights to individual and population-level health conditions. The use of social media creates
potential new problems such as dissemination of poor-quality information, misrepresentation of
healthcare providers words or actions, patient privacy breaches, and the erosion of professional
boundaries between physician and patient.
• Electronic surveys data. The ubiquitousness of Internet access allows for significant transforma-
tion of user surveys that probe the patients attitudes and satisfaction with the healthcare service.
By electronic surveying, one has access to a much bigger and more diverse populations of patients
[93].
In 2017, worldwide digital healthcare data were estimated at about 10,000 Petabytes and are
projected to reach 25,000 Petabytes by 2020. These huge data amounts require use of special
computational methods such as distributed processing, using a MapReduce paradigm implemented
on platforms such as Hadoop, Spark, or Storm.
2.2. Data integration
Dealing with highly heterogeneous medical data requires that they are integrated to take full
advantage of different views of a patient to make the most correct diagnosis. For instance, it may be
required to integrate patients genetic, image, signal, text, numerical and streaming data. Integra-
tion aims to find relationships between different data sources to better diagnose a certain medical
condition [18]. An example is cancer diagnosis, where fMRI data are often combined with genetic
data [75]. Furthermore, it is beneficial to combine individual patients data with population and so-
cial media data to take advantage of all information about a disease. Learning from heterogeneous
data, however, is not trivial due to differences between structured and unstructured data, varying
data quality, their certainty and veracity levels, etc.
The concept of integrating heterogeneous data collected on single patients with data collected
on a population of patients is shown in Figure 1. It illustrates combining signals like EKG (in red),
- omic data (in green), image data like MRI (in blue) and laboratory numerical and text data (in
yellow). We can imagine the integrated data as a matrix shown for individual patients. Physicians
can look at this integrated data to make a diagnosis. However, if similar data on many patients
(a population) are collected and analyzed by data miners, they may discover some patterns that
are not recognizable at a single patient level, and this combined information, when presented to a
physician, can help them to better and with higher confidence diagnose an individual patient.
In other words, population data allow for discovery of more reliable patterns of diseases than
just looking at individual patients. For instance, researchers in Europe analyzed 15,000 patients
and found that people actually have five distinct types of diabetes, not just Type 1 and Type 2 [7].
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Figure 1: Multi-source view of a patient and the data fusion operation.
This would have not been possible without the population-wide study and without using accurate
clustering algorithms.
Dealing with both static (e.g., images) and dynamic data (e.g., streaming data) makes analysis of
data even more complex, as the dynamic data instances arrive continuously. Examples of streaming
data include signals from wearable devices, from in-house sensors, text from social media, or videos
capturing movement of patients at home [117]. Such data require constant updating of machine
learning algorithms [68] and recognizing when statistical characteristics of the incoming data change
over time; a phenomenon called concept drift [91]. Example is a patient initially diagnosed with a
breathing problem but more incoming data may change a diagnosis to a heart problem.
In an intensive care unit patients are connected to multiple sensors and all their measurements
are observed at some control monitor [96]. Doing so allows for detecting disorders more quickly
and reliably than from a brief bedside observation, and thus address them without a delay. Such
intraoperative monitoring has become standard of care for brain and spinal cord surgeries. In
this scenario real time EEG and evoked potential signals are read by a monitoring physician while
a patient is undergoing various brain, carotid artery or spinal cord surgeries. For example, in a
carotid endarterectomy, monitoring allows the physician to detect shunting of blood away from a
potentially vulnerable region of tissue before irreversible ischemic injury occurs. One of the devices
used in ICUs is a mechanical ventilator. One problem with their use is that quite often there
exists a dyssynchrony between the patients own breathing pattern and the steady one forced by
the mechanical ventilator, which causes patients to fight it, which may do more harm than good
for a patient. However, by measuring airflow and using machine learning algorithms detecting in
real time the level of dyssynchrony, an adaptive controller can constantly adjust the mechanical
ventilator airflow to keep it synchronized with the patients breathing [44].
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2.3. Medical Internet of Things (IoT)
Medical IoT is one of the fast growing fields. The idea behind IoT lies in creating a net-
work where people and their smart devices are interconnected. Smartphones, smartwatches, and
smartbands offer on-board sensors as well as significant computational power that allows them to
collect, transfer, and even to some extent process the data as they arrive. As such IoT offers new
opportunities for individual- and population-level medicine [92]. By using lightweight wearable
non-invasive sensors, continuous streams of data are collected on patients in their home environ-
ments, without endangering their privacy [78]. Biomedical signals, activity patterns, movements,
and behaviors can be observed and analyzed in near real-time, giving valuable information about
patients. On a population-level scale, data coming from thousands of patients are analyzed to find
general patterns.Some of IoT characteristics:
IoT network architecture. It is a backbone of IoT [57], responsible for collecting, transmit-
ting, and protecting data, as well as enabling communication among the devices [63]. It consists
of:
• Topology, which represents different components of medical IoT and scenarios [60]. It consists of
data providers (humans, sensors), resource providers (hardware used for computing), and coordi-
nation space responsible for handling data transfers, requests, and results. Sometimes, a physician
or other healthcare professional, such as an athletic trainer, is involved.
• Specification, which refers to IoT physical elements, their organization, principles under which
they operate, and what specific techniques are used. Popular ones include interoperability to
wireless networks (WAN), capability for high-speed data streaming, secure communication between
devices, and data back-ups.
• Platform, which refers to the used computing and software solutions, such as data centers, high-
performance computing clusters [19], MapReduce approaches [28], and software capable of analyzing
data streams in real-time [56], such as SAMOA [81].
Healthcare services in IoT. Medical IoT offers an ever-expanding array of services that are
becoming integrated with the society lifestyles; some of them include:
• Ambient Assisted Living attractive for elderly and people with disabilities [95]. Instead of
relying on human supervision, patients are assisted by intelligent systems capable of monitoring
their condition, improving their physical and/or mental condition, helping with achieving daily
self-care goals, and alerting a health care provider in case of need while preserving patients privacy.
• Community Healthcare allows to collect spatio-temporal data on communities of varying sizes.
This enables analyzing trends and patterns at population-level, finding dependencies between dif-
ferent groups of patients, and analyzing evolution of correlations among multiple health factors.
It is used by patient populations to benefit from social support, which social networks bring. In
a study [113], traumatic brain injury patients were asked to log their selfratings of emotional or
cognitive outcomes on a regular basis and supporters were able to comment on these scores through
a cell phone app. It was shown that participating patients improved performance scores compared
to non-IoT connected controls.
• Semantic Medical Access works with natural language with varied semantics and ontologies [35].
This includes voice command interfaces for smart houses, analyzing unstructured clinical notes, or
extracting useful information from bot-driven conversations with patients.
• Embedded Context Analysis requires understanding of the context related to a specific domain,
as well as incorporating the domain knowledge into machine learning [108]. This is important in
particular for dealing with continuously arriving streams of data that need to be understood from
analytical and medical perspectives.
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3. Medical Data Mining
The term data science is now often used instead of the term data mining so they are used here
interchangeably. In the presentation below, we follow the knowledge discovery process (KDP) [25]
that consists of six steps: Understanding the domain, Understanding the data, Data preprocessing,
Model building, Model validation, and Model deployment [26, 27]. The KDP process is highly
interactive between data miners and data owners, the latter being patients, hospitals and physicians.
It is also highly iterative since if a generated data model is not sufficiently accurate (as shown during
the validation step) data miners have to go back to better understand the domain and data, perform
different data preprocessing operations, etc. [97, 100, 102]. One should remember that the most
important and time consuming of the KDPs six steps is data preprocessing, which takes between
50-70% of the entire data mining effort.
Thanks to technological advancements, the KDP process is now partially automated. The
reason behind this development is that a data miner is needed to analyze data (and even they
spend considerable time doing so), companies designed systems that to a large degree automated
the steps of: preprocessing, model building, and model validation. TPOT, is an open-source tool
that automatically optimizes feature selection methods and data models to maximize accuracy [6].
Another system, DataRobot [2], tests and refines data models; it operates on structured data but
can also find key phrases within unstructured text as well. Quill (Narrative Science) system [5]
is an interesting system that generates from raw input numerical data a data model in a natural
language, i.e., in English, using Natural Language Generation to write a story about the most
important information found in the data; it takes as input structured data only. Loom Systems [4]
take as input structured and unstructured data, either as batch or as streaming data, and visualizes
the generated data models. A popular and free machine learning platform already mentioned,
WEKA, offers hundreds of algorithms for data preprocessing, clustering, classification, regression,
visualization, etc. Its Auto-WEKA version allows for simultaneously selecting a learning algorithm
and setting its parameters for selecting the best model [66]. MOA is popular open-source package
for analyzing streaming data [15].
Another known tool is IBM Watson [40] (commercial) that gained attention in healthcare arena
as it is capable of answering questions formulated in natural language [70]. It can model any do-
main, identifying unique annotation components specific to it. It can process unstructured data
such as books, journals, health records, e-mails, and voice messages. It greatly reduces human
effort and allows for a semi-automated knowledge discovery. It can also perform evidence-based
learning, which allows for creation and improvement of clinical decision support systems. IBM used
Watson to improve cancer detection and treatment. IBM says Watson will be capable of storing a
knowledge base comparable to over 1000 oncology experts and thus offer a new outlook on cancer
data analysis. It should be noted, however, that Watson lacks humanistic data inputs that only
physicians can bring to the decision-making equation. For example, it cannot read facial expres-
sions and know when there is something a patient is not comfortable with. It cannot understand
preconceptions about patients own disease or experiences of friends and family members. It does
not take into account changing social situation, with whom and where a patient lives, ability to
access healthcare providers, general safety and daily habits, or patient moods. Notwithstanding its
weak points Watson, or a similar product, has a potential of becoming a game-changing technology
for healthcare.
It should be noted that the way in which physicians collect data, far from simply going through
a checklist, includes getting to know a patient emotionally and psychologically; this process in itself
is both diagnostic and therapeutic. Physicians know that just listening and holding the hand of
the patient is therapeutic. For these reasons, medicine may always be an art and a science.
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3.1. Medical data preprocessing
Due to the ever-growing size of medical data and their heterogeneous nature two basic operations
are always performed: preprocessing of the data and their integration. The latter was already
described above.
Recall that preprocessing is a very time-consuming step. Some preprocessing methods are
general, whereas other are applicable to specific kinds of data, e.g., only to signals or images.
When we talk about dimensionality of data it in fact refers to three aspects of data: a) the number
of data instances, like the number of patients, b) the number of features/attributes describing data
instances, like different tests performed on a patient, and c) the number of values each attribute
takes on, such weight that is in the range 100 to 500 pounds. The basic preprocessing operations
are instance selection, feature selection, and feature discretization. An instance (data point) is a
singular case of data, such as patient. A feature (attribute) is an observed variable describing each
instance.
Instance selection (IS) focuses on choosing the most important instances while discarding other,
for instance discarding wrongly diagnosed patients data. It is used to remove outliers created
by human or mechanical error during data gathering. IS is especially important in the case of
imbalanced data, where one of the groups is underrepresented compared to the rest, e.g., having
many sick patients data but few normal patients data.
Feature selection (FS) is the process of finding the best feature subset from the original set of
features [46]. See Figure 3 as an example, where only two features were selected for decision making
from the four features measured for a patient. FS is a key technique used with analyzing medical
data where it is important to retain original attributes for model building. Feature extraction (FE)
methods, on the other hand, involve transformation of original features into a new feature space
using techniques such as principal components analysis[42], or neural networks [99, 105].
Another basic preprocessing operation is discretization, which reduces the number of values a
feature takes on. For example, age can be in a range from 0 to 110 years but can be discretized
by grouping ages into intervals such as infants (0-1 year), children (1-12), teenagers (13-18), young
adults (19-30), etc. Discretization is performed with or without taking into account class informa-
tion (like diagnosis). Some algorithms, like CAIM, use the relationship between the feature being
discretized and class to accomplish discretization without the need for a user to specify the number
of bins/discrete intervals [69].
Majority of data mining methods operate on vectors. While this is sufficient for dealing with
many types of medical data, analyzing more complex data structures using vectors can be challeng-
ing. Let us consider video sequences, such as a 4D ultrasonograph, which consist of two-dimensional
frames with three-valued pixels (in RGB system) that are displayed many times per second, thus
adding the 4th feature (time) to data description. In this case, as well as for other images such as
CT, MRI, PET-CT, SPECT, and fMRI a tensor representation (basically a matrix) is better than
vector representation as it preserves spatio-temporal relationships [114].
3.2. Model building
We do not describe here various types of machine learning algorithms used for model building
as they are well covered in many articles and books on data mining [22, 27]. Instead we comment
on deep machine learning, one of the disruptive technologies.
With advances in image acquisition technologies and their growing use in medicine it became
obvious that computers need to be used to perform fast analysis of hundreds or even thousands
of images. There are significant variations between different populations of patients, like male vs
female, Asian vs African-American, etc. The differences can be subtle and not easily identifiable
by the human eye in the images.
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Using techniques such as deep learning (DL), especially one called deep neural networks (DNN),
such differences can be easily found [71, 74]. DNN can automatically select the most important
features and use them to distinguish between [23], say male and female CT images of the heart.
The use of DL in a medical setting may be challenging due to the fact that it usually requires large
data sets to achieve good accuracy, and such data are not easy to acquire for each disease type.
Fortunately, new algorithms can be trained on much smaller data sets [43]. Requirement for having
a big dataset can be alleviated by the usage of the technique of data augmentation, which increases
the volume of the underrepresented images by adding additional images that are distortions to the
original images, e.g., distorted by changing brightness or adding noise.
In spite of great successes of deep neural networks, researchers have also shown their spectacular
failings on image recognitions tasks, which are however trivial to humans. For instance, a trained
DNN was tested on only slightly modified original images used in training. The modification was
such that that there was no perceptible difference to the human eye between the two. Unfortunately,
when the modified original image was used for testing, the network failed to recognize it [106]. In
another work, the researchers modified the image used in training in such a way that it had no
resemblance whatsoever to the original image to the human eye. When used for testing, this image
appearing to the human eye like a TV static noise was not only recognized as a peacock (the original
image) but also with a high accuracy of 99.6% [84].
Creating an efficient data analysis algorithm is a challenging task. A single best algorithm does
not exist; the performance of any algorithm often depends on the type of data being analyzed. This
requires careful selection of a specific algorithm and its parameters, for a specific task. Furthermore,
as we gather more data we cannot assume that the previously trained model is still valid. This
requires involvement of a data mining expert and not blind use of any machine learning software
package, which will always generate some ”results”. Data mining experts, however, may not be
available in smaller hospitals.
3.3. Validating generated models
Validating the generated models of data consist of two stages. First, a data miner uses formal
techniques to assess their quality, such as its goodness of fit (accuracy) and predictive power.
Second, the model (information/knowledge) is presented to medical domain experts who have the
final say on whether what was discovered is truly novel and useful. Only the best model, as assessed
by domain experts can be used in practice.
Formal techniques. They include methods analyzing how well does a given model performs on
training and test data. The approach is to use metrics such as specificity and sensitivity, geometric
mean, F-measure, Area under the ROC curve, Kappa statistic etc [54]. Apart from performance, a
data miner also evaluates stability of the model, i.e., how the results change with small changes in
the input data. In cases where the speed of building a model is important, one should use simpler
methods before using possibly better but more complex ones. Finally, statistical tests are used
to compare different models to check if the differences between them are statistically significantly
different, examples are ranking (e.g., Friedman test) and post-hoc (e.g., Shafer test).
Expert evaluation. Even if a model was found using formal techniques as good and statisti-
cally better than other models, a medical expert must evaluate it and be able to understand why
the model is suggesting a specific diagnosis. Remember that the quality of the generated model
always depends on the quality of the training data. We also must account for imperfections in the
data; a machine learning algorithm may find some correlation in data that would be dismissed by
a physician as wrong, e.g., a correlation between flu resistance and income (which may be true but
not valid).
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3.4. Deployment
Once a model has been validated both formally and by medical experts, the last step in the KDP
is the models deployment. We describe their deployments by means of case studies. They illus-
trate how advancements in machine learning, imaging, AI, and other technologies change medical
practice.
Case study 1: How AI and high resolution imaging changed telemedicine
Telemedicine, aka telehealth, is the use of information and telecommunication technologies to
provide health care service from a distance without a personal visit by a patient. It was first
used by the US military when radiology images were sent over telephone lines. Universities then
used a two-way television system to transmit medical information across campus (University of
Nebraska) or to transmit electrocardiography signals from fire departments to speed up diagnosing
patients in emergency situations (University of Miami). In the 1960s NASA, using microwave
technology, provided health care services to Native Americans as well as to orbiting astronauts.
The spread of telemedicine, however, reached a plateau around 2000s because its widespread use
required sending high definition images and videos through broadband infrastructure, which was
lacking in many communities. New or greatly improved technologies along with better broadband
coverage led to its current massive-scale use. The two technologies that played a key role are machine
learning/artificial intelligence on the one hand, and high-resolution imaging on the other hand. The
reason for the latter is that imaging devices see (their resolution) on the orders of magnitude better
than humans; the same is true for hearing devices. Because of these developments it was possible
to leverage the power of hardware, accompanied by software controlling it, to augment human
perception. These technologies allow for realizing the collaborative human-computer systems that
take advantage of strengths of machines and humans, complementing each other.
AI research started about half-century ago, with great promises, but only recently became
sufficiently fast and accurate to be used in real time. This progress was due to high-performance
distributed computing systems, like Apache Spark, and smart algorithms, like for deep learning.
As a result, telemedicine, because of these two transformative technologies, started to be used on
a massive scale. One case in point is Mercy Health System in Missouri that built and pioneered
the first hospital dedicated entirely to remote care of patients, called Mercy Virtual (MV). It
serves almost a million patients in the Midwest. The MV hospital, without beds but staffed with
nurses and physicians, uses state of the art information technology but patients can use just their
smartphones or tablets to collect and transfer much of the data requested by a physician, or go
to a local clinic to undergo more specialized tests that are transferred to MV. Importantly, before
a physician even sees patient data, they are first processed by AI techniques, resulting in triaging
patients into groups so that physicians can attend to the most seriously ill first. Using AI also speeds
up the process of diagnosing, as it automatically suggests diagnoses, with a low misdiagnosis rate
and avoiding human fatigue which is a significant contributor to medical errors. Advantages of
telemedicine include savings on waiting and travel time for patients, quick access to a physician in
case of emergency, and low-cost monitoring of permanent health conditions, such as diabetes.
It is known that diabetes at later stages of the disease causes diabetic retinopathy, which eventu-
ally leads to blindness. In April 2018, the US Food and Drug Administration approved the first-ever
AI-based software (developed by IDx LLC) for screening diabetic patients for early detection of
the disease. The inputs to the software are images of the retina taken by high-resolution digital
cameras. Many researchers were working for a long time on automating retinopathy quantification
and diagnosis [24], but it takes a company to bring the ideas to the market. The IDx software
was almost 90% accurate in tests for both identifying (test positive) the diabetic retinopathy or
excluding (test negative) it. Only the patients who tested positively would see an ophthalmolo-
gist. This cuts down on wait times to see an ophthalmologist and use of societys resources, e.g.,
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Medicare/Medicaid dollars. It may seem that accuracy below 90% is not good enough but human
experts do not perform better using their (low-resolution) eyes; this is another example of the
growing human-computer complementation of skills.
We envision that telemedicine services will grow significantly in the near future because of new
technologies, including those mentioned above and the new ones that will emerge in the future.
Case study 2: How AI is changing medical diagnostics
China is one of the first countries to use AI technologies on a larger scale to automate the process
of medical diagnosis. It has a great need for such automation because of the size of its population
and a small number of physicians per capita, as compared with the other countries. Interestingly,
Chinese agency, equivalent of the FDA, determined, in 2017, that AI-based diagnosis is a medical
device and as such needs to be approved by it before it can be used in medical practice. Building on
great successes of deep neural network algorithms in image recognition, the most obvious medical
areas for developing first automatic diagnostic algorithms have been in the areas of radiology and
pathology. In fact, this process has been, at least partially, already automated in several countries,
including in the US and India. An algorithm was developed in China to read/diagnose lung images.
The major difference with the situation in China as compared with the US is that the software is
already used at several Chinese hospitals, which deal with thousands of patients per day. Other
Chinese groups develop programs for designing dentures, or for detecting formation of blood clots in
lymphoma treatments [1]. Time will tell whether China will become a leader in automated medical
diagnosis. The advantages that China has over other countries, however, are big and many. For
one, it has less stringent rules about patient data governance than those in place in the EU or
the US. The other one is the top-down way the country is governed so once it has been decided
that medical diagnosis automation is a priority, sufficient funding for achieving this goal is made
available and their companies and scientists have a strong incentive to work on it. Additional
strong motivation for the scientists is knowledge that, once developed, their products will be used
in day-to-day medical practice.
All scientists hope that their work will result in something that can be used for a common good.
And what is more rewarding that knowing that one contributes to human well-being?
Case Study 3: How AI is changing medical diagnostics
AI has potential application in a decision-making process in the field of epilepsy, where 1/3
of patients are medically refractory, meaning that they cannot become seizure free despite the
use of at least 2-3 medication trials at high dosages. The recurrence of seizures has tremendous
social and cognitive consequences, including social handicaps and difficulties with memory, and
communication and alertness. In those refractory cases, the greatest chance of seizure freedom
is surgical resection of the brain tissue which represents the origin of the seizure; applicable only
to those cases in which there is a single, identifiable seizure origin and is far from salient areas
of brain which serve important cognitive or motor functions [90]. In epilepsy surgery candidacy
evaluation, to find the seizure focus physicians employ multiple data points from MRI and/ or
SISCOM images, co-registered MRI with ictal SPECT put together with seizure localization using
EEG, neuropsychological profile from batteries of cognitive and personality testing, interictal PET
scan, and fMRI.
Frequently these data are discordant. For example, the scalp EEG electrodes identify the
right temporal lobe as the seizure focus, but there is a finding of uncertain significance in the left
temporal lobe on MRI and the ictal SPECT shows uptake in the left frontal and temporal regions.
Therefore, there is uncertainty about the focal area of seizure onset. Intracranial EEG recording
is then performed to increase the diagnostic sensitivity and specificity of EEG. The probability
of ascertaining the accurate and precise seizure focus differs depending on a number of predictors
including electrographic features of EEG, seizure phenomenology, the lobe suspected of harboring
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the seizure origin, etc. The best outcome, seizure freedom achieved by surgical resection, is related
to the chance of accurately pinpointing the seizure origin [77].
There are at least two ways in which AI can help. First, use of algorithms for analyzing imaging
such as MRI in a more objective manner than analysis by the human eye can help improve the di-
agnostic sensitivity and specificity of MRI findings. For example, in adult onset refractory epilepsy
a common MRI finding is mesial temporal sclerosis, defined by hippocampal atrophy and MRI
T2-weighted hippocampal hyperintensity. With the discovery that abnormal hippocampi also have
an MRI imaging property called abnormal T2 relaxation times, a data analysis called quantita-
tive magnetic resonance T2 relaxometry has been used to detect evidence of a unilateral abnormal
hippocampus [53]. In addition, software using volumetric measurement is available to characterize
brain structures in a more objective and accurate way than the human eye: FreeSurfer and Neuro-
quant are FDA approved examples. Neuroquant is in wide clinical use to measure temporal lobe
and hippocampal volumes, which improve diagnostic accuracy of entities such as hippocampal scle-
rosis. Good results have been reported for mild traumatic brain injury and Alzheimers dementia
population data [116], on 21 brain regions evaluated [86].
In the future, AI/machine learning will be used to more accurately put together all of the data
points, from both structural and functional brain studies, in patients undergoing epilepsy surgical
candidacy, and potentially others such as how long the patient has had epilepsy, the presumed
etiology, the family history, etc., then a more accurate analysis can be presented to the patient of
how good their prospect of having seizure freedom is with the resection procedure. This would alter
the face of clinical practice and the standard of care, personalizing medicine to a greater degree for
those patients.
Case study 4: How smartphones, wearable devices and social networks impact population health
The issue of elderly care is becoming more important and costly for many countries with aging
populations. The fact is that more seniors want to maintain high quality of life, however, offering
constant human-based monitoring for them would be prohibitive. A global trend of people living
longer brings the need for allowing them to age in their own homes, while still offering medical
assistance that is traditionally attributed to hospitals. Fortunately, the medical IoT technology
allows for continuous remote monitoring of patients in their homes while being non-intrusive [62].
Below we describe a few such solutions.
Canary Care Company deploys battery-powered wireless sensors instead of using wearable de-
vices. The sensors are placed in various locations through the home to constantly monitor the
seniors activity. Their system uses mobile data transfer, so any caregiver, such as family member,
has access to a secure online account allowing them to check the status of the patient. TruSense
is a system that creates an in-home network of mobile devices. These include motion sensors,
contact sensors, smart outlets, hubs, speakers and text-to-voice devices that provide a two-way
communication between a senior and a health care provider or a family member. GPS SmartSole is
another product that combines advantages of mobile devices with inconspicuous design. It embeds
sensors into shoes that an elderly person wears, fusing information from GPS, cellular, Bluetooth,
and Wi-Fi to monitor the state and location of a person. This offers a unique advantage for pa-
tients suffering from Alzheimers, as the product is capable of finding a patient that has wandered
off [8]. One of the largest, the STANLEY Healthcare systems are used by over 5,000 acute care
hospitals and 12,000 long-term care organizations or relatives. Their real-time location system is
connected with each patients electronic medical record. Therefore, a hospital may access real-time
data regarding the location, state, and history of each patient under their care [49].
Case study 5: How big data and data mining techniques allow to model and predict epidemic
outbreaks
Spreading of an epidemic can be modeled using mathematical models fitted to the historic
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data by analyzing spatio-temporal information gathered over multiple outbreaks in multiple places.
Having such a model allows for predicting their potential outbreaks and how will it behave over
time. This, in turn, allows for better preparation for large-scale disease outbreaks, as well as
organizing preventive measures among a population [17]. An example of using big data to improve
understanding of viral diseases was demonstrated by IBM targeting a dangerous and difficult to
contain Ebola virus. The 2014 West Africa outbreak caused deaths of more than 11,000 people,
with more than 28,000 cases reported in Sierra Leone, Liberia, and Guinea. Ebola virus can be
transmitted to a human via direct contact with a host animal (most commonly snake or a bat),
thus entering the local human population. Then it spreads causing outbreaks that are challenging
to contain. Analyzing data from previous Ebola outbreaks lead to identification of new animal
reservoirs, thus increasing population awareness in high-risk regions [12]. IBM used adaptive models
of disease dynamics to accommodate for such properties as virus spreading through direct contact
with infected blood or body fluids (i.e., urine, saliva, feces, vomit, and semen), contaminated objects
(e.g., needles) and infected animals. They highlight the importance of the fact that men who have
recovered from the disease can still transmit the virus through their semen for up to 7 weeks [89].
U.S. Centers for Disease Control (CDC) also used big data techniques for the Ebola surveillance
in several African countries based on collecting and analyzing in real-time text reports coming from
mobile devices. These cheap and fast sources of information give healthcare professionals an edge,
allowing them to track in real-time the evolution of the disease outbreak and spread.
4. Ethical, legal and social issues
Medical data mining must operate under specific conditions and rules, which distinguishes it
from other applications of data mining. One is a close interplay between data mining experts and
medical experts, but there are other factors to be considered when addressing a medical problem
with the help of data science methods.
4.1. Privacy-preserving medical data mining
A key element involved in the quest for preserving data privacy while allowing access to the
data to researchers is de-identification (aka anonymization) of patient records [37, 67]. The NIH
classifies research involving humans as Human Subjects Research (HSR). Privacy threats come
from the possibility of deducing direct identifiers, quasi-identifiers, and other attributes from the
data which can be subject of identity, membership, or attribute disclosures. Privacy models, such
as k-Anonymity, allow assessing privacy risks of the already anonymized data. Anonymization
can also be done by statistical analysis, i.e., removing high entropy variables. In addition to
structured information, medical data contain unstructured text, from which identity information
can be removed only to a smaller degree by using natural language processing (NLP) tools [11]. One
application uses an open source solution for statistical identity scrubbing with little human effort.
Disassociation is another method impeding identification of a patient. It is achieved by partitioning
data into several pieces and thus allowing for independent processing of the pieces. When dealing
with image data, the anonymization also requires checking that no identity information is inserted
into images. One study showed that anonymous sharing and cooperative processing of clinical
and signal data via web services on a multi-center study on deep brain stimulation for Parkinson’s
disease was successful [88].
Privacy issues in medical data analytics are directly related to distributed data mining without
releasing any information regarding the nature of data stored in any of the sources; this is known
as Privacy-preserving data mining [115].
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The European Unions (EU) General Data Protection Regulation (GDPR) [3] of 2018 regulates
the use of personal data, namely, any information relating directly or indirectly to identifiable
people. It is the most radical change in data privacy regulations, which affects collection of data on
EU citizens, their handling and analyses by companies that operate in the EU marketplace. Data, in
particular big data, as such have no value until they are analyzed. Because of the GDRP, however,
certain restrictions also apply to AI and ML algorithms used to analyze human data. Humans,
however, have several rights, for example, article 20 states the data subject (read: patient) shall
have the right to receive the personal data concerning him or her, which he or she has provided to
a controller (read: person/institution storing data) as well as the right to data portability. Article
17 specifies the right to be forgotten. GDRP also strives to allow for easier use of human data for
scientific and medical purposes: Article 6(1) states data subjects should be allowed to give their
consent to certain areas of scientific research when in keeping with recognized ethical standards for
scientific research.
The US and EU have agreement on data sharing, known as the Privacy Shield, but the rules
governing human data use are weaker in the US (e.g., Facebook data breach) than in the EU. Of
more interest for us here is Article 15.1 that states that the data subject has the right to obtain
from the controllers (people responsible for data management) information about the operation
of algorithms used for analyzing data. Although some machine learning algorithms are easy to
understand, such as methods that use original features and generate models in terms of ”IF some
features and their values THEN a certain disease” rules, many are ”black boxes”, such as artificial
neural networks and deep learning algorithms, that lack transparency leading to little, if any, under-
standing of how they arrived at their decisions. Thus how can one be sure that a decision/diagnosis
is accurate? GDPR talks about the ”right to explanation” and the right to obtaining meaningful
information about the logic involved in machine learning, ensuring accountability of automated
decision-making. This could be interpreted in various ways, one of which might be requiring ex-
planation of diagnoses suggested by algorithms operating on human data. This could range from
simply providing basic explanation of how an algorithm works, including specification of its param-
eters and their values. But it could also mean providing all the data on which the algorithm was
trained and tested, plus actual inputs (patient data) used in arriving with a certain diagnosis.
Moreover, since ML algorithms almost never achieve 100% accuracy, which depends on the size
of the training data and the (strong) assumption that new data for which the diagnosis is being
made are similar, meaning that the new data come from the same distribution as the training data.
This is especially important for healthcare data where not only statistical properties of data but
also the background knowledge regarding the analyzed disease must be incorporated and used. For
example, if a model was trained on Asian patient data for a specific disease it should not be used
for prediction on African patients because the prediction results may be entirely wrong, given the
genetic and other differences between the two groups. On the other hand, Asians and Africans may
be very similar in many regards; for example, if both populations have a relatively high prevalence
of a severe variant of multiple sclerosis, then they may have genetic similarity at salient loci. In
general, we stress the need of a physician involvement in semi-automated diagnosis process.
Even if the machine learning model is well understood and used on the same patient population,
it is difficult to say with certainty that a prediction/diagnosis made by it is correct. Typically, if
the model has seen during its training data similar to the new case, then the result is probably
correct. But how is the physician to know that? Fortunately there are some techniques that help
in addressing this problem by providing, in addition to diagnosis, a confidence in the generated
prediction [87].
For example, researchers using Mt Sinais EHR data on 700,000 patients developed a deep neural
network model, called Deep Patient, which was able to predict onset of 78 diseases [79]. The system
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performed better than other systems, in terms of accuracy of predictions, for whether patients will
get sick based on their data. The system performed well for predicting onset of diseases such as
diabetes, schizophrenia and some cancer types, for the time frames of 30, 60, 90 and 180 days, but
poorly for some other diseases. Deep Patient can be used as an aid by physicians to alert patients
that they are at risk for getting a particular disease. The problem, however, is that deep neural
networks are not interpretable. In other words, Deep Patient would not inform physicians why it
has made a particular disease prediction for a given patient, although the prediction is quite reliable
because it was based on analyzing data on hundreds of thousands of patients data.
4.2. Explainable machine learning
There is an ongoing research for developing explainable machine learning/AI techniques, aka
XAI, because of the problem with understanding of models generated by them [80]. In addition,
the models cannot communicate with a human, and most often are not able to provide answer to
a question ”WHY this diagnosis was suggested?”. DARPA was the first to realize the need for ex-
plainability of algorithms used in decision making, and found that different algorithms had different
levels of understanding, as illustrated in Figure 2. As can be seen, the easiest for interpretation,
in terms of explainability, are decision trees. The reason is that their results are written in terms
of rules of the form: IF symptom1=x and symptom2=y and THEN Diagnosis Q; they, however,
are accompanied by low prediction accuracy. At the other end of the spectrum is deep machine
learning with high prediction accuracy but very low explainability [21].
Figure 2: Learning techniques and their explainability (source DARPA (Defense Advanced Research Projects
Agency)).
An example in a medical setting is shown in Figure 3. For a new patient data, described by
four symptoms (as listed there), a previously trained model is used to do the prediction of a flu. If
the model is explainable the physician can ask a question ”why did you decide on the flu?” and the
model would ”answer”: because two symptoms were important in making my decision: ”migraine
was strong” and ”temperature was high”. Seeing this explanation, i.e., reasoning of the system,
the physician would be comfortable in accepting the suggested diagnosis. Using such automated
programs for suggesting diagnoses, would lead to decreasing thousands of diagnostic errors made
in the U.S. hospitals each year (up to 80,000 according to some estimates).
4.3. The ownership of data
One of the challenges of medical data mining is the problem of data ownership that is related
to the issue of Privacy-preserving data mining. Patient data belong to a patient who shares it
with his/her physician. But what happens if data was gathered using federally-sponsored research?
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Figure 3: Explainable machine learning example.
Does a patient still holds full control over data? The issue of anonymization comes into play but
what happens when data was already anonymized? To whom does it then belong? To a patient,
even if he/she cannot link back to her original data? Or to a physician, a data miner, a hospital,
the principal investigator of a grant, or the funding agency [83]?
These issues are further complicated by a growing pressure from the public and funding agencies
that all research must be reproducible, which requires open access to data and algorithms used in
achieving published results. On one hand, this allows for a full reproducibility as anyone could access
the collected medical data. On the other hand, this calls for better methods for data anonymization
[64]. At some point of open data platform development, there will be no distinction between a
scientist who collected data (the owner) and a scientist who just downloaded the data for analysis.
This is a double-edge situation, as data should be shared to allow for medical advancements, but it
can discourage researchers who spend lots of time and effort to generate and curate medical data.
4.4. The lawsuit issue
Medical diagnosis that heavily depends on data mining/AI processing of data will sooner or
later be subject to lawsuits. The problem is confounded by a series of steps leading to a potentially
wrong diagnosis [50]. Is it always a physician, who relied on the semi-automated clinical decision
support system who is ultimately responsible? Or a data scientist who designed an algorithm,
software engineer who implemented it, a nurse and/or technician who collected the data? Can the
fault be proven at all in some cases?
We need to remember that AI/machine learning systems also can and do make mistakes, in
particular when trained on small data sets. Software being a product will be subject to liability
law, even if it cannot be determined why the algorithm failed to recognize a disease correctly. There
is an ongoing discussion how to address this issue, especially in case of personal injury and other
losses caused by the use of machine learning [58]. There are three scenarios for use of machine
learning systems. The first one is when mentally dependent person commits an offence. In this
case, a person is deemed as innocent, but anyone who instructed him/her may be held responsible.
In case of machine learning, a programmer or user may be held responsible. Second scenario is a
natural probable consequence and occurs when the standard actions of an automated system are
used inappropriately, e.g., by an under-trained person. The third scenario is direct liability, where
both action and intent are present, not likely to happen in medicine as it would require a bad intent
from a physician.
Even without employing AI/data mining technologies, the lawsuits in the US medicine still
consume significant amounts of money paid by healthcare providers, physicians, and ultimately
the patients through ever increasing premiums. This should not be the case. New laws should be
enacted regarding usage of medical data to make it much easier to integrate them from different
hospitals. We need to remember, however, that the appearance of malpractice might be a fault of
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simple data-omission or data-transcription errors. The bad outcomes in medicine are not necessarily
exclusively the result of negligent physicians or faulty algorithms.
5. Special status of medicine
Medical sciences have a special status among other disciplines and one needs to be aware of it
when designing data mining methods for diagnostic purposes. Below we review some important
aspects of medicine from the data mining point of view.
• Working with human health and life. Data scientists must be aware of the fact that impor-
tant information is hidden in the data, one that concerns human health and life. A single mistake
may result in a range of complications, including causing undue stress to a patient (incorrect di-
agnosis, especially for a fatal disease), referring a patient for costly and time-consuming additional
tests, or even subjecting a patient to an incorrect, potentially harmful, treatment. The worst po-
tential outcome is false negative diagnosis, which is diagnosing a sick patient as healthy. Therefore,
data scientists need to keep in mind that even one additional correctly predicted case is worth the
time spent on optimizing their models. On the other hand, remembering that perfect diagnosis is
a goal that may never be realized: recall that NIH-approved software for automated diagnosis of
diabetic retinopathy is only correct 80% of the time. Physicians are not always correct either.
• Importance of physician interpretation. Computers cannot and will not replace physicians.
They can only simplify their tasks, reduce fatigue and eliminate human-related errors. For young
physicians, they are also a great tool for skill improvement. Every diagnostic suggestion made by a
machine learning algorithm must be verified by a human expert. This is related to the problem of
responsibility as well as the quest for providing the best medical care possible. That is why medical
data mining develops clinical decision support systems - not clinical decision-making systems.
• Need for constant maintenance. Due to vast amounts of data being generated, as well as
high variation among patients, medical data mining algorithms need to be constantly updated with
new data collected using better technologies (recall the example about imaging techniques). One
cannot assume that a model trained using last years data will accurately diagnose diseases due to
rapid mutations (like in cancer), or antigenic drift (like in influenza), and environmental and social
factors changing and impacting human health.
• Security issues. Privacy preservation is a crucial aspect of medical data mining. Not only we
should avoid leaking personal information and store data in a safe manner, medical data mining
should be aware of the potential presence of malicious agents that may extract patient information
to advance their agenda. This problem is known as adversarial data mining. It assumes that by
providing carefully crafted queries to a data mining system, a malicious user may learn about the
data used to train such an algorithm or force it to adapt to new fake information and thus impair
its capabilities.
6. Conclusions
This article can be seen as a follow-up on our original paper on uniqueness of medical data
mining. It was written because since the time of its publishing rapid advances in technology caused
many changes in how medicine is practiced and even taught. We stressed the increasing role of data
scientists who analyze big, heterogeneous and dynamic medical data. Such analyses often need to
be done in near-real time to provide results when they are needed to be relevant. We also noted the
importance of ethical and legal aspects of medical data mining, which are fluid in spite of national
and international bodies addressing the issues. Constraints imposed by them determine what types
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of data may or not be shared, the manner in which they can be analyzed, and sometimes even the
conclusions that may be drawn and used in practice.
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